Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Genes and Immunity
|
April 12, 2013
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome
T Kalincik, C R G Guttmann, J Krasensky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
D Horakova, J L Cox, E Havrdova, et al.
AJNR. American Journal of Neuroradiology
|
June 27, 2015
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome
M Varosanec, T Uher, D Horakova, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years
R Zivadinov, N Bergsland, O Dolezal, et al.
European Journal of Neurology
|
November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach
T Uher, M Vaneckova, M P Sormani, et al.
Folia Biologica
|
February 18, 2011
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study
D Horáková, M Kýr, E Havrdová, et al.
AJNR. American Journal of Neuroradiology
|
March 3, 2012
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)
Z Seidl, J Vymazal, M Mechl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 26, 2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
E Havrdova, R Zivadinov, J Krasensky, et al.
Alcohol (Fayetteville, N.Y.)
|
March 7, 2017
Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective
O Bezdicek, J Michalec, M Vaneckova, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Genes and Immunity
|
April 12, 2013
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome
T Kalincik, C R G Guttmann, J Krasensky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
D Horakova, J L Cox, E Havrdova, et al.
AJNR. American Journal of Neuroradiology
|
June 27, 2015
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome
M Varosanec, T Uher, D Horakova, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years
R Zivadinov, N Bergsland, O Dolezal, et al.
European Journal of Neurology
|
November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach
T Uher, M Vaneckova, M P Sormani, et al.
Folia Biologica
|
February 18, 2011
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study
D Horáková, M Kýr, E Havrdová, et al.
AJNR. American Journal of Neuroradiology
|
March 3, 2012
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)
Z Seidl, J Vymazal, M Mechl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 26, 2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
E Havrdova, R Zivadinov, J Krasensky, et al.
Alcohol (Fayetteville, N.Y.)
|
March 7, 2017
Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective
O Bezdicek, J Michalec, M Vaneckova, et al.
Page
of 5